Differentiated product

Dapsone

Topical gel (differentiated) · Acne vulgaris

Product data

Dosage form
Topical gel (differentiated)
Dosage-form group
Topical
Therapeutic area
Acne vulgaris
Reference product
Topical gel 5%, 7.5%
Status
POC established / under development
Development stage
1 of 5 · Proof of concept
Portfolio
Differentiated product

Start a conversation

Where does your programme stand?

Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.

Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23

KMS PharmaChennai